Form 4: CVS Health Director Anne Finucane Reports Stock and Deferred Stock Unit Transactions

Director Anne Finucane reports acquisition of CVS Health common stock and deferred stock units related to director compensation.

Summary

• On May 15, 2025, Anne A. Finucane, a director of CVS Health Corp, reported transactions involving the company's stock.
• Finucane acquired 692 shares of common stock at a price of $60.47 per share as payment for a semi-annual retainer under the company's 2017 Incentive Compensation Plan.
• Additionally, Finucane acquired 2,077.4764 deferred stock units due to the deferral of a semi-annual retainer, also valued at $60.47 per unit, under the same plan.
• Following these transactions, Finucane directly owns 14,513.2718 deferred stock units, each convertible into one share of common stock in the future.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard director compensation practices and alignment of interests. There are no indications of negative events or concerns.

Positives

• The acquisition of stock and deferred stock units reflects ongoing director compensation practices at CVS Health.
• The transactions are part of a pre-existing compensation plan, suggesting a structured and transparent approach to director remuneration.

Future Outlook

The document does not contain specific forward-looking statements beyond the standard conversion of deferred stock units into common stock at a future date as elected by the reporting person.

Industry Context

Director compensation through stock and deferred stock units is a common practice in publicly traded companies to align the interests of directors with those of shareholders.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash retainers, equity awards (like stock options or restricted stock), and deferred compensation.
• Companies like Walgreens Boots Alliance (WBA) and UnitedHealth Group (UNH) also utilize similar compensation structures for their directors.
• The specific amounts and types of equity awards can vary based on company size, performance, and industry norms.

Stakeholder Impact

• The transactions have a minor positive impact on shareholders by aligning director interests with company performance.
• Employees are indirectly affected as director compensation is part of the overall corporate governance and financial health of the company.

Key Dates

Keywords

CVS Health, Director Compensation, Form 4, Anne Finucane, Deferred Stock Units, Common Stock, Incentive Compensation Plan, Director